findings home/archives       contact us       other AHC publications   

March 2011 Issue

RSS feed

'Current Controversies' Topic of Internal Medicine Grand Rounds March 16

Published March 2011

The Department of Internal Medicine is sponsoring a special themed medical grand rounds, "Current Controversies in Clinical Medicine Anti-angiogenics in metastatic breast cancer," from noon to 1 p.m. Wednesday, March 16, in Medical Sciences Building Room 7051.

At this "Current Controversies in Clinical Medicine" event, audience members will have the opportunity to participate in a discussion about a controversy that has been raging in the media during the past two months relating to the use of bevacizumab (Avastin) in metastatic breast cancer.

Featured speakers:

 Olivier Rixe, MD, PhD, professor of clinical medicine, division of hematology oncology, will discuss the principles behind anti-angiogenic therapies and their activities in several different types of cancer.

 Mahmoud Charif, MD, assistant professor of clinical medicine, division of hematology oncology, will then discuss the data that led to the approval and later disapproval of bevacizumab by the FDA.

 George Atweh, MD, director of the division of hematology oncology and UC Cancer Institute, will talk about other targeted therapies that have had a dramatic impact on the outcome of patients with other types of cancer.

 Frank Putnam, MD, professor of pediatrics and psychiatry and director of the Mayerson Center for Safe & Healthy Children at Cincinnati Children's Hospital Medical Center, will lead a general discussion of the ethics, economics and the choices we have to make as a society when we use extremely expensive new drugs that result in a modest improvement in survival of patients with cancer.

For more information, contact Mary Rich at or (513) 245-3425.

 back to list | back to top